Hospital Pharmacy Europe - Gastroenterology,

Click here

Thursday 20 June 2013 Register Login

You are here:

Suppliers Guide

New neurology product

Complete an online survey about new products for stroke prevention and receive €225. Click here

LATEST ISSUE

Medication safety, improving patient outcomes, ‘smart’ pump implementation, monitoring of cleanrooms, aclidium bromide in the treatment of COPD, managing pain in renal impairment, labelling, cardiovascular disease risk management, RTU/RTA injections, preventing ischaemic stroke, topical anaesthetics in dermatology, High 5s

Pharmacy Zone: Gastroenterology

Magazine	Sponsored content
News	Video

Tue 12 Mar

Oxycodone–naloxone prolonged-release tablets
Clinical trials of oxycodone–naloxone prolonged-release tablets demonstrate improved bowel function without impairing...

Mon 4 Mar

Bayer’s Stivarga® for treatment of GIST
Bayer HealthCare has announced that the US Food and Drug Administration (FDA) approved Bayer’s Stivarga® (regorafenib)...

Mon 18 Feb

Outcomes data for use of Humira (Adalimumab) in patients with paediatric Crohn's disease
AbbVie (NYSE:ABBV) has announced the first long-term, patient-reported health outcomes data from analyses of the Phase 3...

Mon 19 Nov
2012

Actavis launches generic Pariet® in Europe as patent expires
Actavis Group, the international generic pharmaceuticals company, has announced the launch of Rabeprazole in Germany, France,...

Thu 8 Nov
2012

Albireo granted orphan drug designation for A4250
Albireo AB (Gothenburg, Sweden; “Albireo”), a biopharmaceutical company specialising in gastroenterology, today...

Wed 3 Oct
2012

Final Phase IIb interferon-free hepatitis C
New data from Boehringer Ingelheim's hepatitis C virus (HCV) clinical development programme, HCVersoTM, have been accepted for...

Mon 1 Oct
2012

FDA approves Humira to treat ulcerative colitis
The US Food and Drug Administration today expanded the approved use of Humira (adalimumab) to include treatment of...

Tue 18 Sep
2012

Mesalazine in the treatment of ulcerative colitis
Mesalazine is first-line therapy for the induction and maintenance of remission of mild-to-moderate ulcerative colitis and...

Tue 24 Apr
2012

CHMP maintains refusal to recommend Glybera
After careful consideration of the evidence, the Committee maintained its previous decision

Wed 11 Apr
2012

EU approves Humira for adult ulcerative colitis
Approval in moderate to severely active UC in adults who do not respond to conventional therapy

Tue 4 Oct
2011

Oral antibiotic launched for travellers' diarrhoea
UK Licence granted for Xifaxanta™ (rifaxamin) to treat non-invasive travellers’ diarrhoea

Thu 30 Jun
2011

Gastroenteritis hospitalisation reduced by vaccine
A rotavirus vaccine has decreased the need for hospital admissions in children suffering with severe acute gastroenteritis, a...

Tue 14 Jun
2011

Managing Crohn’s disease
There is a range of drugs for treating Crohn’s disease, and choice is influenced by the balance between efficacy and side...

Mon 6 Jun
2011

Novartis drug shows survival benefit for patients with GIST
Glivec® shows significant overall survival benefit for patients with GIST after three years of adjuvant treatment vs. one...

Web design, hosting and programming by ModeZero